These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 19671906)

  • 21. Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study.
    Huang WW; Hsieh KP; Huang RY; Yang YH
    Kaohsiung J Med Sci; 2017 Jun; 33(6):308-314. PubMed ID: 28601236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aspirin and colorectal cancer: back to the future.
    Tougeron D; Sha D; Manthravadi S; Sinicrope FA
    Clin Cancer Res; 2014 Mar; 20(5):1087-94. PubMed ID: 24327271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regular use of aspirin and pancreatic cancer risk.
    Menezes RJ; Huber KR; Mahoney MC; Moysich KB
    BMC Public Health; 2002 Sep; 2():18. PubMed ID: 12213184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
    Khalaf N; Yuan C; Hamada T; Cao Y; Babic A; Morales-Oyarvide V; Kraft P; Ng K; Giovannucci E; Ogino S; Stampfer M; Cochrane BB; Manson JE; Clish CB; Chan AT; Fuchs CS; Wolpin BM
    Gastroenterology; 2018 Apr; 154(5):1380-1390.e5. PubMed ID: 29229401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I-III Breast Cancer.
    Barron TI; Murphy LM; Brown C; Bennett K; Visvanathan K; Sharp L
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):898-904. PubMed ID: 25791705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
    Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
    J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.
    Zell JA; Ziogas A; Bernstein L; Clarke CA; Deapen D; Largent JA; Neuhausen SL; Stram DO; Ursin G; Anton-Culver H
    Cancer; 2009 Dec; 115(24):5662-71. PubMed ID: 19827153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
    Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
    Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
    Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.
    Kothari N; Kim R; Jorissen RN; Desai J; Tie J; Wong HL; Faragher I; Jones I; Day FL; Li S; Sakthinandeswaren A; Palmieri M; Lipton L; Schell M; Teer JK; Shibata D; Yeatman T; Sieber OM; Gibbs P; Tran B
    Acta Oncol; 2015 Apr; 54(4):487-92. PubMed ID: 25549537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
    Ogino S; Shima K; Baba Y; Nosho K; Irahara N; Kure S; Chen L; Toyoda S; Kirkner GJ; Wang YL; Giovannucci EL; Fuchs CS
    Gastroenterology; 2009 Apr; 136(4):1242-50. PubMed ID: 19186181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
    Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
    Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
    Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
    Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose aspirin use after diagnosis of colorectal cancer does not increase survival: a case-control analysis of a population-based cohort.
    Cardwell CR; Kunzmann AT; Cantwell MM; Hughes C; Baron JA; Powe DG; Murray LJ
    Gastroenterology; 2014 Mar; 146(3):700-708.e2. PubMed ID: 24239563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aspirin use and colorectal cancer: post-trial follow-up data from the Physicians' Health Study.
    Stürmer T; Glynn RJ; Lee IM; Manson JE; Buring JE; Hennekens CH
    Ann Intern Med; 1998 May; 128(9):713-20. PubMed ID: 9556464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspirin dose and duration of use and risk of colorectal cancer in men.
    Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Wu K; Fuchs CS
    Gastroenterology; 2008 Jan; 134(1):21-8. PubMed ID: 18005960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
    Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
    Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PIK3CA Mutation, Aspirin Use after Diagnosis and Survival of Colorectal Cancer. A Systematic Review and Meta-analysis of Epidemiological Studies.
    Paleari L; Puntoni M; Clavarezza M; DeCensi M; Cuzick J; DeCensi A
    Clin Oncol (R Coll Radiol); 2016 May; 28(5):317-26. PubMed ID: 26712086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
    Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
    BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regular Aspirin Use and the Risk of Lethal Prostate Cancer in the Physicians' Health Study.
    Downer MK; Allard CB; Preston MA; Gaziano JM; Stampfer MJ; Mucci LA; Batista JL
    Eur Urol; 2017 Nov; 72(5):821-827. PubMed ID: 28189429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.